Efficacy of Nebulized Dexmedetomidine on Blunting Hemodynamic Changes During Intubation and Pneumoperitoneum in Morbid Obese Patients During Laparoscopic Bariatric Surgery

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions
NebulizationDexmedetomidineHemodynamic ChangesIntubationPneumoperitoneumMorbid ObesityLaparoscopic Bariatric Surgery
Interventions
DRUG

Dexmedetomidine

Patients will be nebulized with dexmedetomidine 1 mcg/kg in 3 ml of 0.9 % saline 15 minutes before shifting the patients to the operating room with a face mask 6 L/min in a sitting position.

DRUG

Normal Saline

Patients will be nebulized with 3 ml of 0.9% normal saline 15 minutes before shifting the patients to the operating room with a face mask, 6 L/min in a sitting position.

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT07054138 - Efficacy of Nebulized Dexmedetomidine on Blunting Hemodynamic Changes During Intubation and Pneumoperitoneum in Morbid Obese Patients During Laparoscopic Bariatric Surgery | Biotech Hunter | Biotech Hunter